The bradykinin B2 receptor agonist (NG291) causes rapid onset of transient blood–brain barrier disruption without evidence of early brain injury - Rodriguez-Massó, Sergio R; Erickson, Michelle A; Banks, William A; Ulrich, Henning; Martins, Antonio Henrique (Frontiers in Neuroscience, 2021)